New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
PDL BioPharma (PDLI)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
77.3M
126M
85.2M
86.0M
91.8M
Cost of Revenue
-3.97M
0
0
0
0
Gross Profit
81.3M
126M
85.2M
86.0M
91.8M
Research & Development
0
0
0
0
0
SG&A
6.95M
5.14M
5.65M
7.73M
7.19M
Amortization & Deprec
3.97M
3.84M
3.50M
3.34M
3.30M
Other Expenses
-90.0K
-4.27M
-5.37M
-8.07M
-7.14M
Total Operating Expenses
10.8M
4.72M
3.78M
3.00M
3.35M
Operating Income
70.5M
121M
81.5M
83.0M
88.5M
Other Income
0
0
0
0
0
EBIT
70.5M
121M
81.5M
83.0M
88.5M
Minority Interest
0
0
0
0
0
Interest Expense
8.70M
7.87M
6.51M
5.95M
6.00M
Income Before Taxes
61.8M
113M
74.9M
77.1M
82.5M
Income Taxes
21.6M
39.8M
26.4M
27.7M
29.0M
Net Income from Continuing Ops
40.2M
73.5M
48.6M
49.4M
53.5M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
40.2M
73.5M
48.6M
49.4M
53.5M
Preferred Dividends
0
0
0
0
0
Net Income to Common
40.2M
73.5M
48.6M
49.4M
53.5M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour